In the News
OncoDaily Interview: Dr. Brody joins host Chandler Park to discuss managing low-grade lymphomas.
The Immunology Podcast: In episode 52 of the Immunology Podcast, Dr. Brody talks about the use of dendritic cells to improve oncolytic virus immunotherapy and in situ vaccination to improve PD-1 blockade responses.
Mount Sinai Feature: Joshua Brody, MD, is an Associate Professor of Hematology and Medical Oncology, and Director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine.
ASCO 2024: Dr. Brody presents groundbreaking results from the ARM5 cohort of the EPCORE NHL-2 trial.
Video Journal of Hematology & HemOnc: Dr. Brody comments on the issue of antigen escape in patients with B-cell lymphomas treated with bispecific antibodies, which can lead to relapse without the target antigen.
Elise meets Dr. Brody: Elise sees first hand what she has been collecting donations for. Learn about the research that LLS (and Elise) support.
ASCO Post: Joshua Brody, MD, of the Icahn School of Medicine at Mount Sinai, summarizes important data on passive and active immunotherapy (Abstracts 1213, 1214, 1215, 1216, 1217, 1218).
Sanjay Gupta: Could Vaccines Cure Cancer?
Mount Sinai Future You: How vaccines are targeting cancer cells